Company / Interest Expense
Cytokinetics Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$45.6M
FY2025
5-year range
$16.4M / $45.6M
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
#14 of 44
Health Care
What the data says
At $46M, Cytokinetics's interest expense ranks #31 of 44 in the Health Care sector. Interest Expense has increased for 9 consecutive years, from $3M in FY2016 to $46M in FY2025.
Based on SEC 10-K filings.
$46M in FY2025 with a 5-year CAGR of +23.3%.
Increased from $28M to $46M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +32.9%
- 5-Year CAGR
- +23.3%
- 10-Year CAGR
- -
Sector benchmark
#31 of 44 in Health CareTop 68% of 44This company $45.6M Sector average $291.0M
▼
-84.3% below sector average
Key checks
Key Insights
- Cytokinetics's interest expense has grown for 9 consecutive years.
- 5-year CAGR of +23.3%, indicating consistent growth.
- In FY2025, interest expense increased 20.9% year-over-year.
- Ranks #14 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.6M | +20.9% |
| FY2024 | $37.7M | +33.2% |
| FY2023 | $28.3M | +45.8% |
| FY2022 | $19.4M | +18.1% |
| FY2021 | $16.4M | +3.0% |
| FY2020 | $16.0M | +141.0% |
| FY2019 | $6.6M | +74.4% |
| FY2018 | $3.8M | +25.9% |
| FY2017 | $3.0M | +11.8% |
| FY2016 | $2.7M | +906.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026